Pharmafile Logo
Pharmafocus logo
Advanced Search
ABPI Code of Practice

Digital Pharma: UK gets social media guidance

April 5, 2011
Medical Communications Code of Practice, Digital Pharma blog, PMCPA, digital marketing

The UK’s Code of Practice regulator has issued guidance on social media and other digital communications tools. It is the …

News
Johnson & Johnson's Tylenol

J&J reorganises McNeil as recalls keep coming

April 5, 2011
Manufacturing and Production J&J, JJ, Johnson & Johnson, McNeil, TBA, TCA, Tylenol, manufacturing compliance, pharma manufacturing, recalls, tribromoanisole, trichloroanisole

Johnson & Johnson has announced a major reworking of its troubled McNeil Consumer Healthcare unit, just as quality problems force …

News

Pfizer sells drug delivery unit Capsugel for $2.38bn

April 5, 2011
Manufacturing and Production Capsugel, Kohlberg Kravis Roberts & Co, Pfizer, pharmaceutical capsules

Pfizer has agreed to sell its Capsugel unit to private equity firm Kohlberg Kravis Roberts & Co. for $2.38 billion …

News
Lansley

Government urged to slow pace of NHS reforms

April 4, 2011
Sales and Marketing GP consortia, Liberating the NHS, NHS reform

The Government should slow down its health reform programme to allow GPs to grow into their new role, the think …

News

Interphex: manufacturing product showcase

April 4, 2011
Manufacturing and Production Interphex, PTI Inspection Systems, Pall Corp

This year’s Interphex exhibition in New York featured the usual crop of new product launches from processing and packaging equipment …

News

China’s new GMP rules will lead to industry consolidation

April 4, 2011
Manufacturing and Production China, GMP

China’s new rules on Good Manufacturing Practice is likely to drive consolidation among the country’s 5,000-plus pharmaceutical companies, according to …

News

New BMS drug trumps peg-interferon alpha

April 4, 2011
Research and Development, Sales and Marketing BMS, EASL, hepatitis C, pegintron alfa

Bristol-Myers Squibb has been given a boost by trial results which suggest its compound for hepatitis C, PEG-Interferon lambda, is …

News

Doubts cast on new Cancer Drugs Fund

April 1, 2011
Cancer Drugs Fund, value-based pricing

There are stark regional variations in the number of doctors using the government’s provisional Cancer Drugs Fund, according to a …

News

Angela Pasma to lead Chiltern’s new Netherlands office

April 1, 2011
Research and Development appointment, chiltern, research and development

Contract research organisation Chiltern has expanded its European operations, opening a new office in the Netherlands. The Leiden office will …

Appointment
Amgen

Amgen’s novel lung cancer drug disappoints in phase III

April 1, 2011
Research and Development Amgen, Millennium, NSCLC, Takeda, motesanib, non-small cell lung cancer

Amgen’s lung cancer drug motesanib has not meet its primary endpoint in a phase III study. The drug, developed in …

News
GlaxoSmitKline

GSK details $28.5m of research payments to US institutions

April 1, 2011
Research and Development GSK, payments

GlaxoSmithKline has made public the payments it gave last year to US institutions engaged in clinical research on its behalf. …

News

TcL Pharma appoints French pharma veterans

April 1, 2011
Research and Development, Sales and Marketing TcL, appointment, biotech, recruitment

TcL Pharma has appointed two seasoned veterans of the French pharmaceutical industry. Dr Jean-Hugues Masgnaux joins the French biotech company …

News

NHS reforms caught in a ‘reality gap’ as dissent grows

March 31, 2011
Andrew Lansley, Liberating the NHS, NHS, NHS reform

The proposed NHS reforms are in danger of failing because of a ‘reality gap’ between the government’s ambitions for change …

News

AstraZeneca pays $1.1bn to resolve tax affairs

March 31, 2011
Sales and Marketing AstraZeneca, tax

AstraZeneca has sorted out a decade-long dispute over its tax affairs by agreeing to pay out $1.1 billion this year. …

News
Cephalon

Valeant makes $5.7 billion hostile bid for Cephalon

March 31, 2011
Research and Development, Sales and Marketing Cephalon, Valeant

Valeant has made a hostile bid for Cephalon, but analysts believe its offer is too low for the deal to …

News

Roche appoints Janet Hammond to translational medicine role

March 31, 2011
Research and Development appointment, research and development

Janet Hammond has joined Roche to drive the early clinical development strategy for its virology discovery and translational area. She …

Appointment

AZ’s Dr Yunxia Bi joins ISP

March 30, 2011
Manufacturing and Production appointment, manufacturing and production

ISP Pharmaceuticals has appointed Dr Yunxia (Vivian) Bi as technical director of its solubility initiative. It is a newly-created position …

Appointment
Erbitux (cetixumab)

Merck re-submits Erbitux to the EMA for lung cancer

March 30, 2011
Sales and Marketing EGFR, Erbitux, Iressa, Merck KGaA, NSCLC, Tarceva, lung cancer drugs, non-small cell lung cancer

Merck KGaA has re-submitted Erbitux’s lung cancer licence extension to the EMA after its first application to the regulator was …

News

Milburn adds his voice to growing disquiet on NHS reforms

March 30, 2011
Alan Milburn, NHS, NHS reforms

Former Labour health secretary Alan Milburn has come out against the government’s health reforms, adding to the chorus of voices …

News

NHS Alliance: Social enterprises are future of public health services

March 30, 2011
NHS, NHS Alliance, NHS reforms, Right to Request, public health services, social enterprise

The NHS Alliance has once more backed the idea that social enterprise should form the backbone of public health services …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026